InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Ferguson Merle. Officer active across 3 companies, notably BIOFORCE NANOSCIENCES HOLDINGS, INC.. In total, 9 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €1m. History available since 30 September 2022. The latest transaction was filed on 17 October 2023 (Don). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Ferguson Merle is a declarant linked to BIOFORCE NANOSCIENCES HOLDINGS, INC., GOLD ROCK HOLDINGS, INC. and Bravo Multinational Inc., where the listed role is CEO for BIOFORCE NANOSCIENCES HOLDINGS, INC. and Bravo Multinational Inc., and President for GOLD ROCK HOLDINGS, INC. Across 9 filings in total, the sampled recent filings from 2022-10-03 to 2023-10-18 show EUR 0 of buys and EUR 1,045,003 of sells, with the transaction nature listed as Don.